A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2017 |
| Author/s |
author: Sandra P D'Angelo Bartosz Chmielowski Dirk Schadendorf |
| Publication date | November 11, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |